Product Images Tepezza
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 2 images provide visual information about the product associated with Tepezza NDC 75987-130 by Horizon Therapeutics Usa, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure 1 - tepezza 01
This is a table showing the change in proptosis (bulging of the eye) from baseline to weeks 12, 18, and 24 for two groups of individuals: a placebo group (N=42) and a TEPEZZA group (N=41). There is no other information available in the text.*
PRINCIPAL DISPLAY PANEL - 500 mg Vial Carton - tepezza 02
TEPEZZA is an injection for intravenous infusion only that contains teprotumumab-trbw. It is supplied as a single-dose vial, which should be discarded if any portion remains unused. The vial packaging is designed to protect its contents from light. Unopened vials must be stored in a refrigerator at 2°C to 8°C (36°F to 46°F), and freezing should be avoided. TEPEZZA has no U.S. standard of potency. The enclosed package insert provides complete information on dosage and administration, including instructions for reconstitution. It is manufactured by Horizon Therapeutics in Denmark and distributed by Horizon Therapeutics USA, Inc.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.